Synthesis,Characterization, and Biological Activities of Pendant Arm‐Pyridyltetrazole Copper(II) Complexes: DNA Binding/Cleavage Activity and Cytotoxic Studies

2‐(1H‐Tetrazol‐5‐yl)pyridine ( L ) has been reacted separately with Me₂NCH₂CH₂Cl?HCl and ClCH₂CH₂OH to yield two regioisomers in each case, N,N‐dimethyl‐2‐[5‐(pyridin‐2‐yl)‐1H‐tetrazol‐1‐yl]ethanamine ( L1 )/N,N‐dimethyl‐2‐[5‐(pyridin‐2‐yl)‐2H‐tetrazol‐2‐yl]ethanamine ( L2 ) and 2‐[5‐(pyridin‐2‐yl)‐1H‐tetrazol‐1‐yl]ethanol ( L3 )/2‐[5‐(pyridin‐2‐yl)‐2H‐tetrazol‐2‐yl]ethanol ( L4 ), respectively. These ligands, L1 – L4 , have been coordinated with CuCl₂?H₂O in 1 : 1 composition to furnish the corresponding complexes 1 – 4 . EPR Spectra of Cu complexes 1 and 3 were characteristic of square planar geometry, with nuclear hyperfine spin 3/2. Single X‐ray crystallographic studies of 3 revealed that the Cu center has a square planar structure. DNA binding studies were carried out by UV/VIS absorption; viscosity and thermal denaturation studies revealed that each of these complexes are avid binders of calf thymus DNA. Investigation of nucleolytic cleavage activities of the complexes was carried out on double‐stranded pBR322 circular plasmid DNA by using a gel electrophoresis experiment under various conditions, where cleavage of DNA takes place by oxidative free‐radical mechanism (OH ^? ). In vitro anticancer activities of the complexes against MCF‐7 (human breast adenocarcinoma) cells revealed that the complexes inhibit the growth of cancer cells. The IC₅₀ values of the complexes showed that Cu complexes exhibit comparable cytotoxic activities compared to the standard drug cisplatin.     

In Vitro Cytotoxic Activities,DNA‐, and BSA‐Binding Studies of a New Dinuclear Copper(II) Complex with N‐[3‐(Dimethylamino)propyl]‐N′‐(2‐carboxylatophenyl)‐ Oxamide as Ligand

A new dinuclear copper(II) complex bridged by N‐[3‐(dimethylamino)propyl]‐N′‐ (2‐carbo‐xylatophenyl)oxamide (H₃dmapob), and endcapped with 2,2′‐diamino‐4,4′‐bithiazole (dabt), namely [Cu₂(dmapob)(dabt)(CH₃OH)(pic)]·(DMF)_0.75·(CH₃OH)_0.25 has been synthesized and characterized by elemental analysis, molar conductivity measurement, infrared and electronic spectra studies, and single‐crystal X‐ray diffraction. In the crystal structure, both copper(II) ions have square–pyramidal coordination geometries. The Cu···Cu separation through the oxamido bridge is 5.176(9) Å. A two‐dimensional supramolecular framework is formed through hydrogen bonds and π–π stacking interactions. The reactivities toward herring sperm DNA and bovine serum albumin (BSA) show that the complex can interact with the DNA via intercalation mode and bind to the BSA responsible for quenching of tryptophan fluorescence by the static quenching mechanism. The in vitro anticancer activities suggest that the copper(II) complex is active against the selected tumor cell lines. The influence of different bridging ligands in dinuclear complexes on the DNA‐ and BSA‐binding properties as well as anticancer activities is preliminarily discussed.     

Synthesis and structure of a new trinuclear nickel(II) complex bridged by N‐[3‐(Dimethylamino)propyl]‐N′‐(2‐hydroxyphenyl)oxamido: in vitro anticancer activities,and reactivities toward DNA and protein

A new trinickel(II) complex bridged by N‐[3‐(dimethylamino)propyl]‐ N ′‐(2‐hydroxylphenyl)oxamido (H₃pdmapo), namely [Ni₃(pdmapo)₂(H₂O)₂]?4CH₃OH, was synthesized and characterized by X‐ray single‐crystal diffraction and other methods. In the molecule, two symmetric cis‐ pdmapo^3? mononickel(II) complexes as a “complex ligand” using the carbonyl oxygen atoms coordinate to the center nickel(II) ion situated on an inversion point. The Ni···Ni distance through the oxamido bridge is 5.2624(4) Å. The center nickel(II) ion and the lateral ones have octahedral and square‐planar coordination geometries, respectively. In the crystal, a three‐dimensional supramolecular network dominated by hydrogen bonds is observed. The reactivity toward DNA/protein bovine serum albumin (BSA) revealed that the complex could interact with herring sperm DNA (HS‐DNA) through the intercalation mode and quench the intrinsic fluorescence of BSA via a static mechanism. The in vitro anticancer activities suggested that the complex is active against the selected tumor cell lines.     

Highly efficient photoactivation of Mn-depleted photosystem II by imidazole-liganded manganese complexes

The oxygen-evolving complex (OEC) of Mn-depleted photosystem II (PSII) can be reconstituted in the presence of exogenous Mn or a Mn complex under weak illumination, a process called photoactivation. Synthetic Mn complexes could provide a powerful system to analyze the assembly of the OEC. In this work, four mononuclear Mn complexes, [(terpy)₂Mn^II(OOCH₃)]·2H₂O (where terpy is 2,2′:6′,2″-terpyridine), Mn^II(bzimpy)₂, Mn^II(bp)₂(CH₃CH₂OH)₂ [where bzimpy is 2,6-bis(2-benzimidazol-2-yl)pyridine] and [Mn^III(HL)(L)(py)(CH₃OH)]CH₃OH (where py is pyridine) were used in photoactivation experiments. Measurements of the photoreduction of 2,6-dichorophenolindophenol and oxygen evolution demonstrate that photoactivation is more efficient when Mn complexes are used instead of MnCl₂ in reconstructed PSII preparations. The most efficient recoveries of oxygen evolution and electron transport activities are obtained from a complex, [Mn^III(HL)(L)(py)(CH₃OH)]CH₃OH, that contains both imidazole and phenol groups. Its recovery of the rate of oxygen evolution is as high as 79% even in the absence of the 33-kDa peptide. The imidazole ligands of the Mn complex probably accelerate P ₆₈₀ ^•+ reduction and consequently facilitate the process of photoactivation. Also, the strong intermolecular hydrogen bond probably facilitates interaction with the Mn-depleted PSII via reorganization of the hydrogen-bonding network, and therefore promotes the recovery of oxygen evolution and electron transport activities.     

Antibacterial,antifungal and in vitro antileukaemia activity of metal complexes with thiosemicarbazones

1‐phenyl‐3‐methyl‐4‐benzoyl‐5‐pyrazolone 4‐ethyl‐thiosemicarbazone (HL) and its copper(II), vanadium(V) and nickel(II) complexes: [Cu(L)(Cl)]·C₂H₅OH·( 1 ), [Cu(L)₂]·H₂O ( 2 ), [Cu(L)(Br)]·H₂O·CH₃OH ( 3 ), [Cu(L)(NO₃)]·2C₂H₅OH ( 4 ), [VO₂(L)]·2H₂O ( 5 ), [Ni(L)₂]·H₂O ( 6 ), were synthesized and characterized. The ligand has been characterized by elemental analyses, IR, ¹H NMR and ¹³C NMR spectroscopy. The tridentate nature of the ligand is evident from the IR spectra. The copper(II), vanadium(V) and nickel(II) complexes have been characterized by different physico‐chemical techniques such as molar conductivity, magnetic susceptibility measurements and electronic, infrared and electron paramagnetic resonance spectral studies. The structures of the ligand and its copper(II) ( 2 , 4 ), and vanadium(V) ( 5 ) complexes have been determined by single‐crystal X‐ray diffraction. The composition of the coordination polyhedron of the central atom in 2 , 4 and 5 is different. The tetrahedral coordination geometry of Cu was found in complex 2 while in complex 4 , it is square planar, in complex 5 the coordination polyhedron of the central ion is distorted square pyramid. The in vitro antibacterial activity of the complexes against Escherichia coli, Salmonella abony, Staphylococcus aureus, Bacillus cereus and the antifungal activity against Candida albicans strains was higher for the metal complexes than for free ligand. The effect of the free ligand and its metal complexes on the proliferation of HL‐60 cells was tested.     

Synthesis and spectroscopic characterization study of new palladium complexes containing bioactive O,O-chelated ligands: evaluation of the DNA/protein BSA interaction,in vitro antitumoural activity and molecular docking

[Pd{(C,N)–C₆H₄CH₂NH(Et) (Qu)] (2) and [Pd{(C,N)–C₆H₄CH₂NH(Et) (Nar)] (3) (Qu = Quercetin, Nar = Naringin) mononuclear palladium (II) complexes have been synthesized and characterized using elemental analysis, IR and electronic spectroscopy. The interaction of the prepared complexes with calf thymus DNA and bovine serum albumin (BSA), monitored by UV–visible and fluorescence titrations, respectively, have been carried out to better understand the mode of their action under biological conditions. Intercalative binding mode between the complexes and DNA is suggested by the binding constant (K_b) values of 2.5 × 10⁶ and 3.2 × 10⁶ for complexes 2 and 3, respectively. In particular, the in vitro cytotoxicity of the complexes on two cancer cells lines (bladder carcinoma TCC and breast cancer MCF7) showed that the compounds had broad spectrum, anti-cancer activity with low IC₅₀ values and the order of in vitro anticancer activities is consistent with the DNA-binding affinities. In the meantime, the quenching of tryptophan emission with the addition of complexes using BSA as a model protein indicated the protein binding ability. The quenching mechanisms of BSA by the complexes were static processes, according to the results obtained. The competitive binding using Warfarin, Digoxin and Ibuprofen site markers, which contain definite biding sites, demonstrated that the complexes bind to site I on BSA. Ultimately, the binding sites of DNA and BSA with the complexes have been determined by molecular modelling studies.     

Synthesis,Structure, and Biological Activities of a New μ‐Oxamido‐Bridged Dicopper(II) Complex: The Influence of Hydrophobicity of Bridging Ligand on DNA Binding and Cytotoxic Activities

A new μ‐oxamido‐bridged dicopper(II) complex, [Cu₂(papo)(H₂O)‐ (phen)]Cl·CH₃OH·H₂O, where H₃papo and phen represent N‐(2‐hydroxyphenyl)‐N'‐(3‐aminopropyl)oxamide and 1,10‐phenanthroline, respectively, has been synthesized and characterized by elemental analysis, molar conductivity measurement, infrared and electronic spectra studies, and single‐crystal X‐ray diffraction. The complex crystallizes in the triclinic space group P‐1. Each copper(II) ion is located in a slightly distorted square‐pyramidal environment. The Cu···Cu distance through the oxamide bridge is 5.1848(7) Å. The three‐dimensional supramolecular structure is built‐up by hydrogen bonds and π–π stacking interactions. The dicopper(II) complex exhibits cytotoxic activity against the SMMC‐7721 and A549 cell lines. The reactivity toward herring sperm DNA and protein bovine serum albumin (BSA) reveals that the dicopper(II) complex can interact with the DNA by the intercalation mode, and effectively quench the intrinsic fluorescence of BSA via a static mechanism. The influence of hydrophobicity of the bridging ligand on DNA‐binding properties and in vitro cytotoxic activities of this kind of dicopper(II) complexes was investigated.     

Enantiomeric Specificity of Biologically Significant Cu(II) and Zn(II) Chromone Complexes Towards DNA

Novel chiral Schiff base ligands (R)/(S)‐2‐amino‐3‐(((1‐hydroxypropan‐2‐yl)imino)methyl)‐4H‐chromen‐4‐one (L₁ and L₂) derived from 2‐amino‐3‐formylchromone and (R/S)‐2‐amino‐1‐propanol and their Cu(II)/Zn(II) complexes ( R1 , S1 , R2 , and S2 ) were synthesized. The complexes were characterized by elemental analysis, infrared (IR), hydrogen (¹H) and carbon (¹³C) nuclear magnetic resonance (NMR), electrospray ionization‐mass spectra (ESI‐MS), and molar conductance measurements. The DNA binding studies of the complexes with calf thymus were carried out by employing different biophysical methods and molecular docking studies that revealed that complexes R1 and S1 prefers the guanine–cytosine‐rich region, whereas R2 and S2 prefers the adenine–thymine residues in the major groove of DNA. The relative trend in K_b values followed the order R1 S1 R2 S2 . This observation together with the findings of circular dichroic and fluorescence studies revealed maximal potential of (R)‐enantiomeric form of complexes to bind DNA. Furthermore, the absorption studies with mononucleotides were also monitored to examine the base‐specific interactions of the complexes that revealed a higher propensity of Cu(II) complexes for guanosine‐5′‐monophosphate disodium salt, whereas Zn(II) complexes preferentially bind to thymidine‐5′‐monophosphate disodium salt. The cleavage activity of R1 and R2 with pBR322 plasmid DNA was examined by gel electrophoresis that revealed that they are good DNA cleavage agents; nevertheless, R1 proved to show better DNA cleavage ability. Topoisomerase II inhibitory activity of complex R1 revealed that the complex inhibits topoisomerase II catalytic activity at a very low concentration (25 μM). Furthermore, in vitro antitumor activity of complexes R1 and S1 were screened against human carcinoma cell lines of different histological origin. Chirality 24:977–986, 2012. © 2012 Wiley Periodicals, Inc.     

Structures and luminescent sensors of mixed‐counterions based salen‐type lanthanide coordination polymers

Reactions of N,N′‐bis (salicylidene)‐1,2‐cyclohexanediamine (H₂L) with mixed lanthanide counterions of LnCl₃·6H₂O and Ln (NO₃)₃·6H₂O afford six H₂L lanthanide coordination polymers, e.g. {[Pr(H₂L)₂(NO₃)₂Cl]·2CH₂Cl₂}_n ( 1 ); {[Ln(H₂L)_1.5(NO₃)₃]₂·5CHCl₃·mCH₃OH}_n [Ln = Sm ( 2 ), Eu ( 3 ), Gd ( 4 ), Tb ( 5 ) and Yb ( 6 ); m = 1 ( 2 – 5 ); m = 0 ( 6 )]. X‐ray crystallographic analysis reveals that complex 1 exhibits three‐dimensional diamondoid topologic structure and complexes 2 – 6 are of two‐dimensional structure. Luminescent spectra show that complexes 1 and 6 have characteristic near‐infrared (NIR) emission of praseodymium (III) and ytterbium (III) ions and complexes 2 – 5 emit luminescence in the visible region. Complexes 3 and 6 reveal sensitive luminescence responses to formaldehyde.     

Tandem crystallization strategies for resolution of 3,3,3‐trifluorolactic acid [CF3CH(OH)COOH] by chiral benzylamines

Resolution of rac‐3,3,3‐trifluorolactic acid by diastereomeric salt formation was reinvestigated. The use of (S)‐1‐phenylethylamine gives coprecipitation of two diastereomeric phases, 1 (S)‐[NH₃CH(CH₃)Ph](S)‐[CF₃CH(OH)COO] and 2 (S)‐[NH₃CH(CH₃)Ph](R)‐[CF₃CH(OH)COO]·H₂O. Pure phase 1 may be obtained using molecular sieves as desiccants. Resolution by (S,S)‐2‐amino‐1‐phenylpropan‐1,3‐diol gives monoclinic (S,S)‐[NH₃CH(CH₂OH)CHOHPh] (R)‐[CF₃CH(OH)‐COO] 3 with minor (S)‐3,3,3‐trifluorolactate contamination, which is precluded in the recrystallized orthorhombic form 4 . A new resolution using inexpensive phenylglycinol gives pure phase 5 (S)‐[NH₃CH(CH₂OH)Ph] (S)‐[CF₃CH(OH)COO] in 76% yield, 94% ee in a single step, in preference to its (S)‐(R) diastereomer 6 . Overall efficient resolution for both enantiomers of the trifluorolactic acid (each ca. 70% yield, 99% ee) may be achieved by various two‐step “tandem” crystallizations, involving direct addition of either water or a second base to the filtrate from the initial reaction.     

Reaction of cyanamide and their derivatives with (η-C5H5)Mn(CO)3 and (η-C5H4CH3)Mn(CO)3

The reaction of cyanamide and its derivatives with the (η⁵-C₅H₅)Mn(CO)₂(THF) and (η⁵-C₅H₄CH₃)Mn(CO)₂(THF) complexes affords the cyanamide substituted complexes of types (η⁵-C₅H₅)Mn(CO)₂(NCN(R′)(R″)) (2a-d) and (η⁵-C₅H₄CH₃)Mn(CO)₂(NCN(R′)(R″)) (3a-e). All complexes were characterized by spectroscopy (¹H, ¹³C NMR, IR), elemental and mass spectroscopy analysis. Complex 2b (η⁵-C₅H₅)Mn(CO)₂(NCN(CH₃)₂) was additionally examined by single crystal X-ray structure determination.     

Synthesis, structures and magnetic properties of oxamido-bridged trinuclear Cu(II)-Mn(II)-Cu(II) complexes

Based on self-assembly of the dissymmetrical mononuclear entity CuL(CH₃OH) [H₂L = (E)-N¹-(2-((2-aminocyclohexydiimino)(phenyl)methyl)-4-chlorophenyl)-N²-(2-benzyl-4-chlorophenyl)oxalamide] with Mn(II), two trinuclear complexes were prepared. They are of the formula [(LCuN₃)₂Mn(CH₃OH)₂] · 2CH₃OH · 2H₂O (1) and [(LCuSCN)₂Mn(H₂O)₂] · 4CH₃OH (2). Their magnetic properties were studied by susceptibility versus temperature measurement, the best fitting of the experimental data led to J = −14.40 cm⁻¹ for 1 and J = −15.48 cm⁻¹ for 2. Hydrogen bonds help complex 1 to produce a novel S type one-dimensional chain-like supramolecular structure. In complex 2, Cl?Cl interaction also results in the formation of a one-dimensional structure.     

Synthesis, characterization, and DNA binding and cleavage properties of copper(II)-tryptophanphenyl-alanine-1,10-phenanthroline/2,2'-bipyridine complexes

The mononuclear dipeptide‐based Cu^II complexes [Cu^II(trp‐phe)(phen)(H₂O)] ⋅ ClO₄ ( 1 ) and [Cu^II(trp‐phe)(bpy)(H₂O)] ⋅ ClO₄ ( 2 ) (trp‐phe=tryptophanphenylalanine, phen=1,10‐phenanthroline, bpy=2,2′‐bipyridine) were isolated, and their interaction with DNA was studied. They exhibit intercalative mode of interaction with DNA. The intercalative interaction was quantified by Stern Volmer quenching constant (K_sq=0.14 for 1 and 0.08 for 2 ). The Cu^II complexes convert supercoiled plasmid DNA into its nicked circular form hydrolytically at physiological conditions at a concentration as low as 5 μM (for 1 ) and 10 μM (for 2 ). The DNA hydrolysis rates at a complex concentration of 50 μM were determined as 1.74 h⁻¹ (R=0.985) for 1 and 0.65 h⁻¹ (R=0.965) for 2 . The rate enhancement in the range of 2.40–4.10×10⁷‐fold compared to non‐catalyzed double‐stranded DNA is significant. This was attributed to the presence of a H₂O molecule in the axial position of the Cu complexes.     

Preparation, structures and properties of dinuclear and trinuclear copper(II) complexes bridged by one oximato and one hydroxo ligands

The dinuclear and trinuclear copper(II) complexes [Cu₂(L)(OH)(ClO₄)(phen)(H₂O)]ClO₄ · [Cu₂(L)(OH)(ClO₄)₂(phen)(CH₃OH)] (1) and [Cu₃(L)₂(OH)₂(H₂O)₂](NO₃)₂ (2) (HL=2-[2-(α-pyridyl)ethyl]imino-3-butanone oxime and phen=1,10-phenanthroline) were prepared and their crystal structures have been determined by X-ray crystallography. Complex 1 is composed of [Cu₂(L)(OH)(ClO₄)(phen)(H₂O)]ClO₄ (1a) and [Cu₂(L)(OH)(ClO₄)₂(phen)(CH₃OH)] (1b). In 1a and 1b, one oximato of L and one hydroxo group bridge two copper(II) ions. The linear trinuclear cation [Cu₃(L)₂(OH)₂(H₂O)₂]²⁺ in 2 is centrosymmetric, and one oximato and one hydroxo group bridge the central and terminal copper(II) ions. The strong antiferromagnetic interactions within the dinuclear and trinuclear complexes 1 and 2 have been observed (2J=∼−900 cm⁻¹ for 1 and 2, respectively, H=−2JS₁·S₂).     

Cyclic and acyclic compartmental Schiff bases, their reduced analogues and related mononuclear and heterodinuclear complexes

[1+1] macrocyclic and [1+2] macroacyclic compartmental ligands (H₂L), containing one N₂O₂, N₃O₂, N₂O₃, N₄O₂ or O₂N₂O₂ Schiff base site and one O₂O_n (n=3, 4) crown-ether like site, have been prepared by self-condensation of the appropriate formyl- and amine precursors. The template procedure in the presence of sodium ion afforded Na₂(L) or Na(HL) · nH₂O. When reacted with the appropriate transition metal acetate hydrate, H₂L form M(L) · nH₂O, M(HL)(CH₃COO) · nH₂O, M(H₂L)(X)₂ · nH₂O (M=Cu²⁺, Co²⁺, Ni²⁺; X=CH₃COO⁻, Cl⁻) or Mn(L)(CH₃COO) · nH₂O according to the experimental conditions used. The same complexes have been prepared by condensation of the appropriate precursors in the presence of the desired metal ion. The Schiff bases H₂L have been reduced by NaBH₄ to the related polyamine derivatives H₂R, which form, when reacted with the appropriate metal ions, M(H₂R)(X)₂ (M= Co²⁺, Ni²⁺; X=CH₃COO⁻, Cl⁻), Cu(R) · nH₂O and Mn(R)(CH₃COO) · nH₂O. The prepared ligands and related complexes have been characterized by IR, NMR and mass spectrometry. The [1+1] cyclic nature of the macrocyclic polyamine systems and the site occupancy of sodium ion have been ascertained, at least for the sodium (I) complex with the macrocyclic ligand containing one N₃O₂ Schiff base and one O₂O₃ crown-ether like coordination chamber, by an X-ray structural determination. In this complex the asymmetric unit consists of one cyclic molecule of the ligand coordinated to a sodium ion by the five oxygen atoms of the ligand. The coordination geometry of the sodium ion can be described as a pentagonal pyramid with the metal ion occupying the vertex. In the mononuclear complexes with H₂L or H₂R the transition metal ion invariantly occupies the Schiff base site; the sodium ion, on the contrary, prefers the crown-ether like site. Accordingly, the heterodinuclear complexes [MNa(L)(CH₃COO)_x] (M=Cu²⁺, Co²⁺, Ni², x=1; M=Mn³⁺, x=2) have been synthesised by reacting the appropriate formyl and amine precursors in the presence of M(CH₃COO)_n · nH₂O and NaOH in a 1:1:1:2 molar ratio. The reaction of the mononuclear transition metal complexes with Na(CH₃COO) · nH₂O gives rise to the same heterodinuclear complexes. Similarly [MNa(R)(CH₃COO)_x] have been prepared by reaction of the appropriate polyamine ligand H₂R with the desired metal acetate hydrate and NaOH in 1:1:2 molar ratio.     

Crystallographic studies for the chiral recognition of the novel chiral stationary phase derived from (+)‐(R)‐18‐crown‐6 tetracarboxylic acid

Chiral discrimination observed in high‐performance liquid chromatography (HPLC) with the novel chiral stationary phase (CSP‐18C6I) derived from (+)‐(R)‐18‐crown‐6 tetracarboxylic acid [(+)‐18C6H₄] was investigated by X‐ray crystallographic analysis of the complex composed of the R‐enantiomer of 1‐(1‐naphthyl)ethylamine (1‐NEA) and (+)‐18C6H₄. Mixtures of 1‐NEA (the R‐ or S‐enantiomer) and (+)‐18C6H₄ were dissolved in methanol‐water (1:1) solution and allowed to stand for crystallization. The R‐enantiomer crystallized with (+)‐18C6H₄ as a co‐crystal, although the S‐enantiomer did not. This result was in good agreement with the enantiomer elution order of 1‐NEA in CSP‐18C6I. The apparent binding constants (K_a) of the enantiomers to the (+)‐18C6H₄ obtained from ¹H‐NMR experiments also supported the above‐mentioned result. The X‐ray crystal structure of the 1:1 complex of the R‐enantiomer and (+)‐18C6H₄ indicated the four sets of hydrogen bond association between the naphthylethylammonium cation and oxygen of polyether ring or carbonyl group of (+)‐18C6H₄. Chirality 11:173–178, 1999. © 1999 Wiley‐Liss, Inc.     

Novel dioxomolybdenum(VI) and oxomolybdenum(V) complexes with pyridoxal thiosemicarbazone ligands: Synthesis and structural characterisation

New molybdenum complexes were prepared by the reaction of [Mo^VIO₂(acac)₂] or (NH₄)₂[Mo^VOCl₅] with different N-substituted pyridoxal thiosemicarbazone ligands (H₂L¹ = pyridoxal 4-phenylthiosemicarbazone; H₂L² = pyridoxal 4-methylthiosemicarbazone, H₂L³ = pyridoxal thiosemicarbazone). The investigation of monomeric [MoO₂L¹(CH₃OH)] or polymeric [MoO₂L^1-3] molybdenum(VI) complexes revealed that molybdenum is coordinated with a tridentate doubly-deprotonated ligand. In the oxomolybdenum(V) complexes [MoOCl₂(HL^1-3)] the pyridoxal thiosemicarbazonato ligands are tridentate mono-deprotonated. Crystal and molecular structures of molybdenum(VI) [MoO₂L¹(CH₃OH)]·CH₃OH, and molybdenum(V) complexes [MoOCl₂(HL¹)]·C₂H₅OH, as well as of the pyridoxal thiosemicarbazone ligand methanol solvate H₂L³·MeOH, were determined by the single crystal X-ray diffraction method.     

Mn(II) complexes of monoanionic bidentate chelators: X-ray crystal structures of Mn(dha)2(CH3OH)2 (Hdha = dehydroacetic acid) and [Mn(ema)2(H2O)]2 · 2H2O (Hema = 2-ethyl-3-hydroxy-4-pyrone)

This report describes synthesis and characterization of bis-ligand Mn(II) complexes of bidentate chelators: maltol (3-hydroxy-2-methyl-4-pyrone), ethylmaltol (2-ethyl-3-hydroxy-4-pyrone), 1,2-dimethyl-3-hydroxy-4-pyridinone (DMHP) and dehydroacetic acid. All four Mn(II) complexes were characterized by elemental analysis, IR, UV/Vis, EPR, cyclic voltammetry, and X-ray crystallography in cases of Mn(dha)₂(CH₃OH)₂ and [Mn(ema)₂(H₂O)]₂ · 2H₂O. The bidentate chelator plays a significant role in the solid state structure of its Mn(II) complex. For example, dha forms the monomeric complex Mn(dha)₂(CH₃OH)₂ while ethylmaltol forms the dimeric complex [Mn(ema)₂(H₂O)]₂. Because of smaller size, maltol ligands in Mn(ma)₂ are able to bridge adjacent Mn(II) centers to give a polymeric structure in solid state. Despite of the difference in their solid state structures, both Mn(ema)₂ and Mn(ma)₂ exist in solution as monomeric Mn(II) species, Mn(ema)₂(H₂O)₂ and Mn(ma)₂(H₂O)₂. This assumption is supported by the similarity in their UV/Vis spectra, EPR data and electrochemical properties. Replacing maltol with DMHP results in a decrease (by ∼100 mV) in the redox potential for the Mn(II)/Mn(III) couple, suggesting that DMHP stabilizes Mn(III) better than maltol. Since Mn(DMHP)₂(H₂O)₂ is readily oxidized to form the more stable Mn(III) complex Mn(DMHP)₃, DMHP has the potential as a chelator for removal of excess Mn(II) from patients with chronic Mn toxicity.     

GC (Guanine‐Cytosine)‐Selective DNA‐Binding and Antitumor Activity of a Quercetin?Manganese(II) Complex

The DNA binding and cleavage properties of quercetin? manganese(II) complexes have been studied, but little attention has been devoted to the relationship between the antitumor activity of these complexes and the DNA‐binding properties. Here, the DNA binding properties of the quercetin? manganese(II) complex [Mn(Que)₂(H₂O)₂] were studied using UV/VIS and fluorescence spectroscopy and viscosity measurements. The results indicate that the complex was preferentially bound to DNA in the GC (guanine? cytosine)‐rich regions via an intercalative mode. Furthermore, the cytotoxicity experiments confirmed its apoptosis‐inducing activity. We also demonstrated that the levels of survivin protein expression in HepG2 cells decreased and that the relative activity of caspase‐3 significantly increased after treatment with the complex. Hence, our results suggest that the antitumor activity of the [Mn(Que)₂(H₂O)₂] complex might be related to its intercalation into DNA and its DNA‐binding selectivity.     

Synthesis,crystal structure and fluorescence properties of terbium complexes with phenoxyacetic acid and 2,4,6‐tris‐(2‐pyridyl)‐s–triazine

Two complexes of Tb³⁺, Gd³⁺/Tb³⁺ and one heteronuclear crystal Gd³⁺/Tb³⁺ with phenoxyacetic acid (HPOA) and 2,4,6‐tris‐(2‐pyridyl)‐s–triazine (TPTZ) have been synthesized. Elemental analysis, rare earth coordination titration, inductively coupled plasma atomic emission spectrometry (ICP‐AES) and thermogravimetric analysis‐differential scanning calorimetry (TG‐DSC) analysis show that the two complexes are Tb₂(POA)₆(TPTZ)₂·6H₂O and TbGd(POA)₆(TPTZ)₂·6H₂O, respectively. The crystal structure of TbGd(POA)₆(TPTZ)₂·2CH₃OH was determined using single‐crystal X‐ray diffraction. The monocrystal belongs to the triclinic system with the P‐1 space group. In particular, each metal ion is coordinately bonded to three nitrogen atoms of one TPTZ and seven oxygen atoms of three phenoxyacetic ions. Furthermore, there exist two coordinate forms between C₆H₅OCH₂COO^– and the metal ions in the crystal. One is a chelating bidentate, the other is chelating and bridge coordinating. Fluorescence determination shows that the two complexes possess strong fluorescence emissions. Furthermore, the fluorescence intensity of the Gd³⁺/Tb³⁺ complex is much stronger than that of the undoped complex, which may result from a decrease in the concentration quench of Tb³⁺ ions, and intramolecular energy transfer from the ligands coordinated with Gd³⁺ ions to Tb³⁺ ions. Copyright © 2015 John Wiley & Sons, Ltd.